BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 22006780)

  • 1. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007.
    Chen AY; Fedewa S; Zhu J
    Arch Otolaryngol Head Neck Surg; 2011 Oct; 137(10):1017-24. PubMed ID: 22006780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of comorbidity on treatment (chemoradiation and laryngectomy) of advanced, nondistant metastatic laryngeal cancer: a review of 16 849 cases from the national cancer database (2003-2008).
    Zhu J; Fedewa S; Chen AY
    Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1120-8. PubMed ID: 23247231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer.
    Chen AY; Fedewa S; Pavluck A; Ward EM
    Cancer; 2010 Oct; 116(20):4744-52. PubMed ID: 20589761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis?
    Chen AY; Schrag NM; Halpern M; Stewart A; Ward EM
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):784-90. PubMed ID: 17709617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predictive of survival in advanced laryngeal cancer.
    Chen AY; Halpern M
    Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1270-6. PubMed ID: 18086971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival.
    Dziegielewski PT; O'Connell DA; Klein M; Fung C; Singh P; Alex Mlynarek M; Fung D; Harris JR; Seikaly H
    J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S56-64. PubMed ID: 22569051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of treatment on survival in patients with advanced laryngeal carcinoma.
    Gourin CG; Conger BT; Sheils WC; Bilodeau PA; Coleman TA; Porubsky ES
    Laryngoscope; 2009 Jul; 119(7):1312-7. PubMed ID: 19444887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvements in survival and disparities for advanced-stage laryngeal cancer.
    LeBlanc BJ; Shi R; Mehta V; Mills G; Ampil F; Nathan CA
    JAMA Otolaryngol Head Neck Surg; 2015 Feb; 141(2):169-73. PubMed ID: 25429594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of outcome for advanced-stage supraglottic laryngeal cancer.
    Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle J; Wong RJ; Lee N; Pfister DG; Shaha AR; Shah JP
    Head Neck; 2009 Nov; 31(11):1489-95. PubMed ID: 19408292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.
    Hoffman HT; Porter K; Karnell LH; Cooper JS; Weber RS; Langer CJ; Ang KK; Gay G; Stewart A; Robinson RA
    Laryngoscope; 2006 Sep; 116(9 Pt 2 Suppl 111):1-13. PubMed ID: 16946667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of curative effects on laryngeal carcinoma patients in the northeast region of China.
    Ji W; Guan C; Pan Z
    Acta Otolaryngol; 2008 May; 128(5):574-7. PubMed ID: 18421614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional outcomes following treatment for advanced laryngeal cancer. Part I--Voice preservation in advanced laryngeal cancer. Part II--Laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group.
    Hillman RE; Walsh MJ; Wolf GT; Fisher SG; Hong WK
    Ann Otol Rhinol Laryngol Suppl; 1998 May; 172():1-27. PubMed ID: 9597955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in treatment of advanced laryngeal cancer 1985-2001.
    Chen AY; Schrag N; Hao Y; Flanders WD; Kepner J; Stewart A; Ward E
    Otolaryngol Head Neck Surg; 2006 Dec; 135(6):831-7. PubMed ID: 17141069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival outcomes in advanced laryngeal cancer.
    Megwalu UC; Sikora AG
    JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):855-60. PubMed ID: 25144163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated transoral laser microsurgery for early and advanced recurrence of early glottic cancer after primary laser resection.
    Roedel RM; Matthias C; Wolff HA; Christiansen H
    Auris Nasus Larynx; 2010 Jun; 37(3):340-6. PubMed ID: 19700251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor volumetry as a prognostic factor in the management of T4a laryngeal cancer.
    Hsin LJ; Fang TJ; Tsang NM; Chin SC; Yen TC; Li HY; Liao CT; Chen IH
    Laryngoscope; 2014 May; 124(5):1134-40. PubMed ID: 24127228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.